Biotech · Private company
Implicit Bioscience
Track this companyFree. Adds Implicit Bioscience to your Dealase workspace and tells you when its record changes.
Clinical trials53 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- AtibuclimabPhase 2 · Acute Respiratory Distress SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- Atibuclimab (IC14)Phase 2 · Acute Decompensated Heart FailureClinicalTrials.gov · fetched Nov 12, 2026
- Atibuclimab (IC14), 20 mg/kg intravenously, oncePhase 2 · STEMIClinicalTrials.gov · fetched Nov 12, 2026
- IC14Phase 2 · Arrhythmogenic Right Ventricular DysplasiaClinicalTrials.gov · fetched Nov 12, 2026
- IC14Amyotrophic Lateral SclerosisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- Anti-CD14 Treatment With IC14 in Hospitalized ARDS PatientsPHASE2 · RECRUITING · started Jun 17, 2026ClinicalTrials.gov NCT06513949 · fetched Nov 12, 2026
- Pilot Study of IC14 (Atibuclimab), an Anti-CD14 Monoclonal Antibody, to Treat STEMIPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Feb 6, 2025ClinicalTrials.gov NCT06678074 · fetched Nov 12, 2026
- IC14 for Treatment of Acute Decompensated Heart FailurePHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Oct 17, 2024ClinicalTrials.gov NCT06556810 · fetched Nov 12, 2026
- IC14 (Atibuclimab) in Arrhythmogenic CardiomyopathyPHASE1_PHASE2 · COMPLETED · started Mar 29, 2024ClinicalTrials.gov NCT06275893 · fetched Nov 12, 2026
- IC14 for ALS Patients Expanded AccessNO_LONGER_AVAILABLEClinicalTrials.gov NCT04309604 · fetched Nov 12, 2026